The company is preparing to embark on a clinical study of what would be the first orally-taken home treatment for Crohn’s Disease using a...
Small caps
Market Preview
ECJ CBD ruling and Biden election victory could spark investment surge into global cannabis sector
Both events could herald a regulatory sea change in two huge markets for the industry
The pharma giant could reap the long-term benefits from higher reputation – ‘no vax’ movements...
The FTSE 100 firm dipped after posting lower efficacy than its competitors, but the upside lies...
The ultra-cold temperatures needed by Pfizer's jab may be a significant hurdle for its distribution
Dr Tim Franklin, Chief Operating Officer of ImmuPharma PLC (LON:IMM) joins Proactive London's Katie Pilbeam to discuss ImmuPharma's announcement that The US Food & Drug Administration (“FDA”) has confirmed 4th December 2020 will be the date for the Type ‘A’ Meeting Request, with Avion...
Pharma & Biotech
Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial...
Pharma & Biotech
Sensyne Health present at the Proactive One2One virtual investment...
Pharma & Biotech
Open Orphan present at the Proactive One2one virtual investment forum
Pharma & Biotech
Market report: FTSE falls as New York schools get set to close
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
